Literature DB >> 24973194

Prevalence and predictors of blood-brain barrier damage in the HAART era.

A Calcagno1, M C Alberione, A Romito, D Imperiale, V Ghisetti, S Audagnotto, F Lipani, S Raviolo, G Di Perri, S Bonora.   

Abstract

Blood-brain barrier damage (BBBD) is prevalent in HIV-positive patients and may enhance cell trafficking to the central nervous system. A retrospective analysis in adult HIV-positive patients with no central nervous system disease was conducted in order to estimate the prevalence and risk factors of BBBD (according to cerebrospinal fluid to plasma albumin ratios). One hundred fifty-eight HIV-positive adult patients were included. BBBD impairment and intrathecal IgG synthesis were respectively observed in 45 (28.5 %) and 100 patients (63.3 %). Low CD4 nadir and high CSF HIV RNA were independently associated with both abnormalities. BBBD is common in HIV-positive patients, and its main determinants are advanced immune depression and compartmental viral replication.

Entities:  

Mesh:

Year:  2014        PMID: 24973194     DOI: 10.1007/s13365-014-0266-2

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  26 in total

1.  Oligoclonal IgG bands in Japanese multiple sclerosis patients.

Authors:  I Nakashima; K Fujihara; Y Itoyama
Journal:  J Neuroimmunol       Date:  1999-11-15       Impact factor: 3.478

Review 2.  Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis.

Authors:  W W Tourtellotte; B I Ma
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

3.  CSF changes in a longitudinal study of 124 neurologically normal HIV-1-infected U.S. Air Force personnel.

Authors:  D W Marshall; R L Brey; C A Butzin; D R Lucey; S M Abbadessa; R N Boswell
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

4.  External quality assessment in clinical neurochemistry: survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/serum quotients.

Authors:  H Reiber
Journal:  Clin Chem       Date:  1995-02       Impact factor: 8.327

5.  Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients.

Authors:  S Abdulle; L Hagberg; M Gisslén
Journal:  HIV Med       Date:  2005-05       Impact factor: 3.180

6.  Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals--correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels.

Authors:  L M Andersson; L Hagberg; D Fuchs; B Svennerholm; M Gisslén
Journal:  J Neurovirol       Date:  2001-12       Impact factor: 2.643

7.  Blood-cerebrospinal fluid barrier permeability in Alzheimer's disease.

Authors:  Sonia Chalbot; Henrik Zetterberg; Kaj Blennow; Tormod Fladby; Niels Andreasen; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

8.  Cerebrospinal fluid analysis in human immunodeficiency virus infection.

Authors:  C D Hall; C R Snyder; K R Robertson; J A Messenheimer; J W Wilkins; W T Robertson; R A Whaley; C Van der Horst; L M Silverman
Journal:  Ann Clin Lab Sci       Date:  1992 May-Jun       Impact factor: 1.256

9.  Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain.

Authors:  C K Petito; K S Cash
Journal:  Ann Neurol       Date:  1992-11       Impact factor: 10.422

10.  Raltegravir cerebrospinal fluid concentrations in HIV-1 infection.

Authors:  Aylin Yilmaz; Magnus Gisslén; Serena Spudich; Evelyn Lee; Anura Jayewardene; Francesca Aweeka; Richard W Price
Journal:  PLoS One       Date:  2009-09-01       Impact factor: 3.240

View more
  13 in total

Review 1.  Treating HIV Infection in the Central Nervous System.

Authors:  A Calcagno; G Di Perri; S Bonora
Journal:  Drugs       Date:  2017-02       Impact factor: 9.546

2.  Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection.

Authors:  Sérgio M de Almeida; Indianara Rotta; Clea E Ribeiro; Davey Smith; Ruiyi Wang; Jennifer Judicello; Michael Potter; Florin Vaida; Scott Letendre; Ronald J Ellis
Journal:  J Neuroimmunol       Date:  2016-11-03       Impact factor: 3.478

Review 3.  Ageing with HIV: a multidisciplinary review.

Authors:  A Calcagno; S Nozza; C Muss; B M Celesia; F Carli; S Piconi; G V De Socio; A M Cattelan; G Orofino; D Ripamonti; A Riva; G Di Perri
Journal:  Infection       Date:  2015-05-19       Impact factor: 3.553

4.  The Impact of Paracoccidioides spp Infection on Central Nervous System Cell Junctional Complexes.

Authors:  Sérgio Monteiro de Almeida; Amanda Kulik; Mineia Alessandra Scaranello Malaquias; Seigo Nagashima; Caroline Busatta Vaz de Paula; Marisol Dominguez Muro; Lucia de Noronha
Journal:  Mycopathologia       Date:  2022-08-03       Impact factor: 3.785

5.  Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis.

Authors:  A Calcagno; A Romito; C Atzori; V Ghisetti; C Cardellino; S Audagnotto; E Scarvaglieri; F Lipani; D Imperiale; G Di Perri; S Bonora
Journal:  J Neuroimmune Pharmacol       Date:  2016-11-08       Impact factor: 4.147

Review 6.  Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.

Authors:  Andrea Calcagno; Giovanni Di Perri; Stefano Bonora
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

7.  Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients.

Authors:  A Calcagno; C Atzori; A Romito; D Vai; S Audagnotto; M L Stella; C Montrucchio; D Imperiale; G Di Perri; S Bonora
Journal:  J Neurovirol       Date:  2015-08-06       Impact factor: 2.643

Review 8.  Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals.

Authors:  Jacinta Nwamaka Nwogu; Qing Ma; Chinedum Peace Babalola; Waheed Adeola Adedeji; Gene D Morse; Babafemi Taiwo
Journal:  AIDS Res Treat       Date:  2016-09-29

9.  Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers.

Authors:  Giulia Caligaris; Mattia Trunfio; Valeria Ghisetti; Jessica Cusato; Marco Nigra; Cristiana Atzori; Daniele Imperiale; Stefano Bonora; Giovanni Di Perri; Andrea Calcagno
Journal:  Diagnostics (Basel)       Date:  2021-05-12

10.  Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients.

Authors:  Ceereena Ubaida-Mohien; Benjamin Lamberty; Alex M Dickens; Michelle M Mielke; Thomas Marcotte; Ned Sacktor; Igor Grant; Scott Letendre; Donald Franklin; Pawel Cibrowski; Ravi Tharakan; Justin C McArthur; Howard Fox; Norman J Haughey
Journal:  AIDS       Date:  2017-06-19       Impact factor: 4.632

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.